ZURICH, April 26 The Swiss blue-chip SMI
was seen opening 0.12 percent higher at 8,786 points on
Wednesday, according to premarket indications by bank Julius
The following are some of the main factors expected to
affect Swiss stocks:
The Zurich-based bank will raise around 4 billion Swiss
francs ($4 billion) through a rights offering to catch up to
European rivals on capital, while ditching plans to float a
minority stake in its Swiss unit. Credit Suisse said net income
was 596 million francs. Analysts polled by Reuters had expected
net profit of 423 million francs.
Credit Suisse shares were seen opening 0.87 percent higher,
according to premarket indicators.
For more click
The Swiss-listed device maker is looking for bolt-on
acquisitions, its chief executive officer said, though the
company is not dependent on them for growth. Logitech said
full-year operating income grew 53 percent to $197 million.
For more click
* Baloise Holding AG said its public takeover bid
for Pax Anlage AG had been completed.
* Varia Us Properties Ltd said fully year profit
was $16.2 million, of which $8.9 million was attributable to
* Roche said new data it is presenting at a
conference reinforce clinical benefit of its Ocrevus medicine
for relapsing and primary progressive multiple sclerosis.
* Dufry said HNA Group has announced it exceeded
the threshold of 15 percent due to an agreement with third
parties to purchase 16.79 percent of the shares of Dufry AG.
* Lonza said it expects to raise 2.25 billion Swiss
francs by issuing up to 22 million new shares in a capital
* ChemChina reconfirmed the timeline for public offers for
Syngenta shares and said all regulatory approvals and
conditions required for closing of offers have been obtained.
* Spice Private Equity said it will launch a
sharebuyback of up to 386,000 shares in a scheme that will
launch on April 26.
* Aevis Victoria said it had updated its offer to
purchase LifeWatch after Biotelemetry made a
competing offer earlier this month.
* Also Holding AG said it formed a strategic
partnership with HP Inc. to market its new A3 printing
* Kuros Biosciences said its full-year net loss
more than tripled to 19.7 million francs as it intensified its
research and development activities.
* Syngenta said four of Syngenta’s existing board
members will become independent directors after ChemChina takes
control, with four other members stepping down.
The UBS Swiss consumption indicator rose to 1.50 in March
from a revised 1.45 in February, the Swiss bank's economists
said on Wednesday.
The Swiss Investor Sentiment Index is due to be published at
($1 = 0.9921 Swiss francs)
(Reporting by Zurich newsroom)